Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT

SCL Hewer, AR Smyth, M Brown… - Health …, 2021 - livrepository.liverpool.ac.uk
Background People with cystic fibrosis are susceptible to pulmonary infection with
Pseudomonas aeruginosa. This may become chronic and lead to increased mortality and …

[HTML][HTML] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT

SC Langton Hewer, AR Smyth… - Health Technology …, 2021 - eprints.whiterose.ac.uk
Background People with cystic fibrosis are susceptible to pulmonary infection with
Pseudomonas aeruginosa. This may become chronic and lead to increased mortality and …

[PDF][PDF] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis

SCL Hewer, AR Smyth, M Brown, AP Jones… - Health Technology …, 2021 - core.ac.uk
Health Technology Assessment (HTA) research is undertaken where some evidence
already exists to show that a technology can be effective and this needs to be compared to …

Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.

LH SC, AR Smyth, M Brown, AP Jones… - Health Technology …, 2021 - europepmc.org
Background People with cystic fibrosis are susceptible to pulmonary infection with
Pseudomonas aeruginosa. This may become chronic and lead to increased mortality and …

[PDF][PDF] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis

SCL Hewer, AR Smyth, M Brown… - Health Technology …, 2021 - pureadmin.qub.ac.uk
Simon C Langton Hewer, 1, 2*† Alan R Smyth, 3† Michaela Brown, 4 Ashley P Jones, 4
Helen Hickey, 4 Dervla Kenna, 5 Deborah Ashby, 6 Alexander Thompson, 7 Laura Sutton, 4 …

[PDF][PDF] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis

SCL Hewer, AR Smyth, M Brown… - Health Technology …, 2021 - scholar.archive.org
Simon C Langton Hewer, 1, 2*† Alan R Smyth, 3† Michaela Brown, 4 Ashley P Jones, 4
Helen Hickey, 4 Dervla Kenna, 5 Deborah Ashby, 6 Alexander Thompson, 7 Laura Sutton, 4 …

[PDF][PDF] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis

SCL Hewer, AR Smyth… - Health …, 2021 - nottingham-repository.worktribe.com
Simon C Langton Hewer, 1, 2*† Alan R Smyth, 3† Michaela Brown, 4 Ashley P Jones, 4
Helen Hickey, 4 Dervla Kenna, 5 Deborah Ashby, 6 Alexander Thompson, 7 Laura Sutton, 4 …

Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT

SCL Hewer, AR Smyth, M Brown, AP Jones, H Hickey… - 2021 - pubmed.ncbi.nlm.nih.gov
Background People with cystic fibrosis are susceptible to pulmonary infection with
Pseudomonas aeruginosa. This may become chronic and lead to increased mortality and …

[引用][C] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT

SC Langton Hewer, AR Smyth… - Health Technology …, 2021 - journalslibrary.nihr.ac.uk
Background People with cystic fibrosis are susceptible to pulmonary infection with
Pseudomonas aeruginosa. This may become chronic and lead to increased mortality and …

[HTML][HTML] Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT

SCL Hewer, AR Smyth, M Brown, AP Jones… - Health Technology …, 2021 - pure.qub.ac.uk
Background: People with cystic fibrosis are susceptible to pulmonary infection with
Pseudomonas aeruginosa. This may become chronic and lead to increased mortality and …